DrugPatentWatch Database Preview
Chlorpromazine hydrochloride - Generic Drug Details
What are the generic drug sources for chlorpromazine hydrochloride and what is the scope of freedom to operate?
Chlorpromazine hydrochloride
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Hikma, Fosun Pharma, Abraxis Pharm, Dr Reddys, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Upsher Smith Labs, Vangard, West Ward, and Parke Davis, and is included in sixty-four NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-four drug master file entries for chlorpromazine hydrochloride. Eleven suppliers are listed for this compound.
Summary for chlorpromazine hydrochloride
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 26 |
| NDAs: | 64 |
| Drug Master File Entries: | 24 |
| Suppliers / Packagers: | 11 |
| Bulk Api Vendors: | 89 |
| Clinical Trials: | 28 |
| Patent Applications: | 3,223 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | chlorpromazine hydrochloride at DailyMed |
Recent Clinical Trials for chlorpromazine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Second Affiliated Hospital of Nanchang University | Phase 4 |
| Hopital Psychiatrique De La Croix | Phase 4 |
| University of Nottingham | Phase 4 |
Pharmacology for chlorpromazine hydrochloride
| Drug Class | Phenothiazine |
Synonyms for chlorpromazine hydrochloride
| [3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-dimethylamine hydrochloride |
| [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride |
| [3-(2-chlorophenothiazin-10-yl)propyl]dimethylamine, chloride |
| 012C654 |
| 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine monohydrochloride |
| 10-[3-(dimethylamino)propyl]-2-chlorophenothiazine hydrochloride |
| 10H-phenothiazine-10-propanamine hydrochloride, 2-chloro-N,N-dimethyl- |
| 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, hydrochloride (1:1) |
| 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, monohydrochloride |
| 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine monohydrochloride |
| 2-chloro-10-(3-dimethylaminopropyl) phenothiazine hydrochloride |
| 2-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride |
| 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine hydrochloride |
| 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine hydrochloride; CPZ; Largactil |
| 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine monohydrochloride |
| 2-Chloro-10-[3-(dimethylamino)-1-propyl]phenothiazine Hydrochloride |
| 2-Chloro-10-[3-dimethylamino-propyl] phenothiazine |
| 2-Chloro-10-[3′-(dimethylamino)propyl]phenothiazine, HCl |
| 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine hydrochloride |
| 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine hydrochloride |
| 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine hydrochloride |
| 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride |
| 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride. |
| 4560 Rp hydrochloride |
| 69-09-0 |
| 9WP59609J6 |
| AB0013284 |
| AB1009377 |
| AC-10573 |
| AC1L1M3I |
| AC1LCWF1 |
| AC1Q3BDA |
| AI3-28023 |
| AKOS005111082 |
| Aminazin monohydrochloride |
| Aminazinum |
| Ampliactil monohydrochloride |
| AN-23781 |
| ANW-42443 |
| ARONIS23911 |
| C 8138 |
| C-165 |
| C07952 |
| C17H19ClN2S.HCl |
| CAS-69-09-0 |
| CCG-220064 |
| CCG-221553 |
| CCRIS 6221 |
| CHEBI:3649 |
| CHEMBL1713 |
| Chloractil |
| Chloropromazin hydrochloride |
| CHLOROPROMAZINE HYDROCHLORIDE |
| Chloropromazine monohydrochloride |
| Chlorpromazine (hydrochloride) |
| Chlorpromazine chloride |
| Chlorpromazine Hcl |
| Chlorpromazine hydrochloride (JP17/USP) |
| Chlorpromazine hydrochloride [USAN:BAN:JAN] |
| Chlorpromazine hydrochloride [USP:BAN:JAN] |
| Chlorpromazine Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Chlorpromazine Hydrochloride Intensol |
| Chlorpromazine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
| Chlorpromazine hydrochloride, >=98% (TLC) |
| Chlorpromazine hydrochloride, 98% |
| Chlorpromazine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Chlorpromazine hydrochloride, meets USP testing specifications |
| Chlorpromazine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Chlorpromazine hydrochloride, VETRANAL(TM), analytical standard |
| Chlorpromazine monohydrochloride |
| Chlorpromazine-d6 Hydrochloride |
| Chlorpromazine, Hydrochloride |
| ChlorpromazineHydrochloride,98% |
| Chlorpromazinium chloride |
| Contomin hydrochloride |
| CPD000058254 |
| CPZ |
| CPZ (VAN) |
| CS-2507 |
| CTK8B3386 |
| D00789 |
| DSSTox_CID_4827 |
| DSSTox_GSID_24827 |
| DSSTox_RID_77545 |
| DTXSID7024827 |
| EINECS 200-701-3 |
| EU-0100249 |
| FBSMERQALIEGJT-UHFFFAOYSA-N |
| Fenactil monohydrochloride |
| FT-0623715 |
| H818 |
| Hebanil |
| Hibanil |
| Hibernal |
| HMS1568M09 |
| HY-B0407A |
| Hybernal |
| Klorproman |
| Klorpromex |
| KS-00000V46 |
| Largactil monohydrochloride |
| Largaktyl |
| Lomazine |
| LP00249 |
| LS-1585 |
| Marazine |
| MCULE-8792081568 |
| Megaphen hydrochloride |
| Megatil |
| MFCD00012654 |
| MLS-0090820.0001 |
| MLS000069401 |
| MLS001148603 |
| MLS002222157 |
| MolPort-003-928-768 |
| NC00552 |
| NCGC00024409-09 |
| NCGC00093711-01 |
| NCGC00093711-02 |
| NCGC00180973-01 |
| NCGC00254272-01 |
| NCGC00260934-01 |
| NCI-C05210 |
| Neurazine |
| Norcozine |
| NSC 17479 |
| NSC-17479 |
| NSC-226514 |
| NSC17479 |
| NSC226514 |
| Opera_ID_1294 |
| Phenothiazine hydrochloride |
| Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-, monohydrochloride |
| Plegomazin |
| Prestwick_58 |
| Promachel |
| Promacid |
| Promapar |
| Promexin |
| Propaphen |
| Propaphenin |
| Q-200842 |
| s2456 |
| SAM002548952 |
| SAM002564196 |
| SBB057793 |
| SC-18311 |
| SCHEMBL41771 |
| SMR000058254 |
| Sonazine |
| Sonazine (TN) |
| SR-01000000012 |
| SR-01000000012-2 |
| SR-01000000012-9 |
| ST50331291 |
| SW196373-5 |
| Taroctyl |
| Thorazine hydrochloride |
| Tox21_300517 |
| Tox21_500249 |
| TR-031509 |
| Tranzine |
| UNII-9WP59609J6 |
| Unitensen |
| WLN: T C666 BN ISJ B3N1&1 EG &GH |
| Z1259155914 |
US Patents and Regulatory Information for chlorpromazine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purepac Pharm | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 080403-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Glaxosmithkline | THORAZINE | chlorpromazine hydrochloride | TABLET;ORAL | 009149-018 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Cycle Pharms Ltd | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 085331-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Ivax Sub Teva Pharms | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 083549-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Pvt Form | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 080340-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
